US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ホーム
投資
株式
ドイツ
TG
Hugo Boss AG (BOSS) 銘柄情報

Hugo Boss AG (BOSS)

35.48

-0.060001

(-0.17%)

終了 6月6日 5:00AM

Hugo Boss AG (BOSS) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

35.48

( -0.17% )

買値

35.36

売値

35.60

出来高

2,232

35.35 日の範囲 35.86

0.00 52 週間の範囲 0.00

時価総額

前日終値

35.54

始値

35.35

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

434,354 €

発行済株式数

69,016,167

配当利回り

0.04 (0.11%)

PER

10.78

1 株当たり利益 (EPS)

3.33

歳入

4.18B

純利益

231.48M

Hugo Boss AG, together with its subsidiaries, provides apparel, shoes, and accessories for men and women worldwide. It offers licensed products, such as fragrances, eyewear, and watches. The company also provides sportswear for tennis and padel, gym and running, ski, golf, equestrian, and swimming. ... Hugo Boss AG, together with its subsidiaries, provides apparel, shoes, and accessories for men and women worldwide. It offers licensed products, such as fragrances, eyewear, and watches. The company also provides sportswear for tennis and padel, gym and running, ski, golf, equestrian, and swimming. It markets and sells its products under the BOSS and HUGO brand names through freestanding stores, shop-in-shops, factory outlets, multi-brand stores, and franchise business, as well as online retailers, distribution, and stores. The company was founded in 1924 and is based in Metzingen, Germany. 詳細を表示

セクター

Consumer Discretionary

業界

Apparel & Luxury

ウェブサイト

www.hugoboss.com

本社

Metzingen, Germany

設立

2026

Hugo Boss AG is listed in the Consumer Discretionary sector of the Tradegate (DE) with ticker BOSS. The last closing price for Hugo Boss was 35.54 €. Over the last year, Hugo Boss shares have traded in a share price range of 0.00 € to 0.00 €.

Hugo Boss currently has 69,016,167 shares in issue. The market capitalisation of Hugo Boss is 2.45 € billion. Hugo Boss has a price to earnings ratio (PE ratio) of 10.78.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

BOSS - Frequently Asked Questions (FAQ)

What is the current Hugo Boss AG share price?

The current share price of Hugo Boss AG is 35.48 €

How many Hugo Boss AG shares are in issue?

Hugo Boss AG has 69,016,167 shares in issue

What is the market cap of Hugo Boss AG?

The market capitalisation of Hugo Boss AG is EUR 2.45B

What is the 1 year trading range for Hugo Boss AG share price?

Hugo Boss AG has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Hugo Boss AG?

The price to earnings ratio of Hugo Boss AG is 10.78

What is the cash to sales ratio of Hugo Boss AG?

The cash to sales ratio of Hugo Boss AG is 0.59

What is the registered address of Hugo Boss AG?

The registered address for Hugo Boss AG is Holy-Allee 3, Metzingen, Baden-Württemberg, 72555

What is the Hugo Boss AG website address?

The website address for Hugo Boss AG is www.hugoboss.com

Which industry sector does Hugo Boss AG operate in?

Hugo Boss AG operates in the Apparel & Luxury sector

US Market News

US Market News 4分前

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA BerobenatideJune 6, 2026 9:00 AM
Business Wire Results from multiple Phase 2b dose finding studies for berobenatide (PF’3944) highlight a potential first-in

Investor082

Investor082 4分前

They are all a bunch of BS artists! They have trapped many naive retail families over the years by providing false hope and expectations.

Investor082

Investor082 6分前

See you in 2028 then! LP is likely to abandon Eden before that at some point than secure a commercial certification in 2028.

Keep a ton of dry powder. Looking forward to you bragging about averaging down in the coming weeks and months, LOL! ;)

Investor082

Investor082 9分前

In that case, forget about 2026 and 2027. Likely 2028 as well. C lab and Eden won’t certified for commercial production until 2028 at the earliest. Its more likely they will abandon Eden than secure commercial certification even in 2028. Have fun with the endless dilution in pennies! ;)

WhiteOwl

WhiteOwl 10分前

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

hardlesson

hardlesson 13分前

You're one of the hardest working guys on ihub. Banging out the charts on a Saturday morning. Thanks always, and have a good weekend. :)

Investor082

Investor082 13分前

LP will be back there again in a couple years still pleading for a change (pathway act) so she can submit regulatory application to FDA in 2030, LOL!

Meanwhile outstanding shares ballooned to 5B+, LOL! ;)

WhiteOwl

WhiteOwl 14分前

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

glenn1919

glenn1919 17分前

BCDA......BMGL.......BGMS......ACCL......CMND.........CGTL...........https://stockcharts.com/sc3/ui/?s=CMND&p=w&yr=1&mn=3&dy=0&id=p96837884856

Investor082

Investor082 18分前

No excuses when LP disappoints on this, OK?

I will check in on this message whenever there is a decision, LOL! ;)

WhenLambo

WhenLambo 18分前

FIFA is already on public record marketing them, what could be bigger than that? They’ll continue to put VuMe out there next week

train21

train21 19分前

DRIVEN IS BACK
so I guess we going to see 5 cents again ? well are we ?

Investor082

Investor082 20分前

Don't let LP and her toxic financiers screw you year after year, LOL! ;)

Instead invest in well known AI and tech stocks run by solid management crew.

glenn1919

glenn1919 22分前

STAK......SPHL.....SMTK......SAOR.....SNBR.......SCAG.....SPPL..................................https://stockcharts.com/sc3/ui/?s=SCAG&p=w&yr=1&mn=3&dy=0&id=p96837884856

jackinthegreen

jackinthegreen 22分前

Exactly - another round of press and hype can drive the price up a bit, but without substantial new contracts and revenue outside the consumer electronics space, it will only be a temporary bump. We’ve been here before - buying on the rumor is great, but what we need is actual profitability.

train21

train21 22分前

BOTH CEOs BLOCKED ME ON X
I MUST HAVE HIT THE NAIL ON THE HEAD
ANY CEO THAT BLOCKS QUESTIONS OF THEIR DECISIONS IS HIDING SOMETHING BIG AND BAD ???

rodman

rodman 23分前

There appears to be some life left in UEEC based upon the buying and pps increase this week.

cottonmather

cottonmather 23分前

Drey Dossier. The WH Ballroom ain't what it used to be. 17 minutes https://youtu.be/VbJ4ilDvGyc?si=DispyZYqLVQNJyms

USAFpatriot

USAFpatriot 23分前

Annual meeting 8k.

https://investorshub.advfn.com/stock-market/NASDAQ/novocure-NVCR/stock-news/98686681/form-8-k-current-report

train21

train21 24分前

$GTVH YOU ALL NEED TO FILE COMPLAINTS ON THE $OTC WEB SITE AND THE $FINRA WEB SITE
I CAN NOT JUST BE THE ONLY ONE FILING COMPLAINTS HERE ? SOME OF YOU GUYS LOST THOUSANDS $$$$$
CASEY IS A SHARE SELLING SCAMMMER AND MEDIA POSTING LIAR ......... AND THATS ALL THIS STOCK IS

HGiLS

Absolutely — let’s build the full, structured deep-dive you asked for. Below is everything:

• All Eliquis ANDA filers
• Their litigation outcomes
• Each filer’s non-infringement arguments
• Why none succeeded
• Drugs where generics did win using alternative

peafunke

peafunke 26分前

You told ‘who’ so? The fifa concerts are this coming week.

HGiLS

Yes — Eliquis (apixaban) has exactly the kind of ANDA litigation you’re asking about: cases where a generic filer challenged the Orange Book patents and argued non-infringement because their own formulation or manufacturing approach did not fall within the scope of the listed patents.

Teddytropics

Teddytropics 29分前

I will leave it up to you to decide..

I ask myself.. why is this guy so obsessed with Jason Black..?

That he wants to 'to tell on Jason Black' to all..

Where Jason Black isn't involved here anymore except for the CNNA OTC page still listing him..

Blue World Acquisition

0.125% until 10/14/2026 ...

Energy Resources Of Aust...

Atrato Onsite Energy

Amundi Core Global Aggre...

Outlook Therapeutics

Ls 3x Long India Etp

PCI Biotech Holding Asa

American Mobile Dental (EM)

AAB National (EM)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。